share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer WAGNER CHARLES F JR

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer WAGNER CHARLES F JR

福泰制药 | 4:持股变动声明-高管 WAGNER CHARLES F JR
美股SEC公告 ·  06/05 16:18

Moomoo AI 已提取核心信息

Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 3,250 shares of common stock on June 3, 2024. The transaction was executed at a price of $460.00 per share, resulting in a total sale value of $1,495,000. Following the sale, Wagner's direct holdings in the company amount to 47,137 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 3,250 shares of common stock on June 3, 2024. The transaction was executed at a price of $460.00 per share, resulting in a total sale value of $1,495,000. Following the sale, Wagner's direct holdings in the company amount to 47,137 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
致富金融(临时代码)的埃维普和首席财务官查尔斯F.瓦格纳(Charles F. Wagner Jr.)于2024年6月3日出售了3250股普通股。此次交易价格为每股460.00美元,总销售价值为149.5万美元。出售后,瓦格纳在公司的直接持股数量为47137股普通股。该交易是在公司最新提交的文件中以公开市场交易的形式进行的。
致富金融(临时代码)的埃维普和首席财务官查尔斯F.瓦格纳(Charles F. Wagner Jr.)于2024年6月3日出售了3250股普通股。此次交易价格为每股460.00美元,总销售价值为149.5万美元。出售后,瓦格纳在公司的直接持股数量为47137股普通股。该交易是在公司最新提交的文件中以公开市场交易的形式进行的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息